Clinical Trial Update: Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating doxorubicin and cyclophosphamide followed by docetaxel with lapatinib in stage II/III HER2-positive breast cancer completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)
• Doxorubicin (doxorubicin)
• Lapatinib (Lapatinib)

Snippet

Sponsor: George Albert Fisher | Conditions: Breast Cancer, Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-12-22